Clinical Trial Update: Total Lymphoid Irradiation (TLI) to Prevent Focal Segmental Glomerulosclerosis (FSGS)Recurrence in the Renal Graft [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating total lymphoid irradiation to prevent recurrence of focal segmental glomerulosclerosis in renal transplant recipients. The study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Segmental Glomerulosclerosis

Drugs mentioned

• Total lymphoid irradiation

Snippet

Sponsor: University of Sao Paulo | Conditions: Glomerulosclerosis, Focal | Phase 1 | Status: COMPLETED